Advanced Enzyme Technologies (ADVENZYMES.NS) Stock Price
Advanced Enzyme Technologies Price
Over the last 18 years Advanced Enzyme Technologies grew revenue by 14.9% annually, reaching 7.46 B INR. Earnings per share have grown at 21.5% per year over the last 18 years. For Advanced Enzyme Technologies, the net margin of 22.6% is broadly stable versus 22.6% a few years ago. At today's price the dividend yield works out to roughly 0.45%. The payout ratio is around 47% of earnings. The dividend has grown at 13.0% per year over the past 9 years. The consensus 12-month price target for Advanced Enzyme Technologies is 448.80 INR, about 66.4% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Advanced Enzyme Technologies stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Advanced Enzyme Technologies business model & stock analysis
Frequently asked questions about Advanced Enzyme Technologies
Analysts currently set an average price target of 448.80 INR for the Advanced Enzyme Technologies stock (median: 448.80 INR), implying +66.4 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Advanced Enzyme Technologies stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Advanced Enzyme Technologies share trades at 2.53 EUR (269.65 INR).
The Advanced Enzyme Technologies share (ADVENZYMES.NS) is listed on 2 stock exchanges, including: NSE (Indien) (ADVENZYMES.NS).
The revenue of Advanced Enzyme Technologies is 7.46 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Advanced Enzyme Technologies is 1.69 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Advanced Enzyme Technologies is currently 17.90. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Advanced Enzyme Technologies stock.
The price-to-sales ratio (P/S) of Advanced Enzyme Technologies is currently 4.05. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Advanced Enzyme Technologies stock.
The Eulerpool Quality Score for Advanced Enzyme Technologies is 6/10.
The ISIN of Advanced Enzyme Technologies is INE837H01020. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Advanced Enzyme Technologies is ADVENZYMES.NS. The ticker symbol is used to trade Advanced Enzyme Technologies shares on the stock exchange.
Advanced Enzyme Technologies stock
Advanced Enzyme Technologies Peer Group
Advanced Enzyme Technologies Ticker
Advanced Enzyme Technologies FIGI
All fundamentals and in-depth analysis of Advanced Enzyme Technologies
Our stock analysis for Advanced Enzyme Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Advanced Enzyme Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.